Series A startup

Who invested in TNAX Biopharma

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$4.6Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $4.6MNov 2019
Investors
3
See who backed them

The rounds

  1. Nov 2019
    Series A$4.6M

    Source recorded

Everyone who backed them

Nissay CapitalVC firm1round
JAFCOCompany1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about TNAX Biopharma

Who invested in TNAX Biopharma?

TNAX Biopharma's investors include Mitsubishi UFJ Capital, Nissay Capital and JAFCO.

How much has TNAX Biopharma raised?

TNAX Biopharma has raised $4.6M across 1 round since 2019.

When did TNAX Biopharma last raise?

TNAX Biopharma's most recent round was a Series A of $4.6M in Nov 2019.

What was TNAX Biopharma's biggest round?

Its most recent round, $4.6M in Nov 2019, is also its largest on record.

Who backed TNAX Biopharma first?

TNAX Biopharma's first round on record, in Nov 2019, was backed by Mitsubishi UFJ Capital, Nissay Capital and JAFCO.

What stage is TNAX Biopharma at?

TNAX Biopharma's latest named round is a Series A, in Nov 2019.

Companies like TNAX Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.